The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Items 601–700 of 1,000
Wu, P., Hsieh, W., Cheng, Y., Wei, C., & Chou, P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064310e · Cited by 33
Xiao, W., Zhou, W., Ma, Q., Cui, W., Mei, Q., & Zhao, X. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104310 · Cited by 31
Chen, H.-S., Wang, J., Li, H., Wang, X., Zhang, S.-Q., Deng, T., Li, Y.-K., Zou, R.-S., Wang, H.-J., Zhu, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn2496 · Cited by 32
Chronic depression as a model disease for cerebral aging
Bewernick, B. H., & Schlaepfer, T. E. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.1/bbewernick · Cited by 36
D’Andrea, G., Ceccarelli, M., Bernini, R., Clemente, M. E. N., Santi, L., Caruso, C., Micheli, L., & Tirone, F. (2020) · The FASEB Journal · doi:10.1096/fj.201902643r · Cited by 36
Blood Transfusion in Clinical Practice
(2012) · InTech eBooks · doi:10.5772/1868 · Cited by 31
NK1receptor antagonists under investigation for the treatment of affective disorders
Czéh, B., Fuchs, E., & Simon, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.5.479 · Cited by 34
“More contemporary theories suggest that disturbed neuroplasticity, including impaired cytogenesis, might form the basis of major depression [32-34].”
BackgroundSemenkovich, K. A., Chockalingam, R., Scherrer, J. F., Panagopoulos, V. N., Lustman, P. J., Ray, J. M., Freedland, K. E., & Švrakić, D. M. (2014) · Europe PMC (PubMed Central) · Cited by 39
Benefits of animal models to understand the pathophysiology of depressive disorders
Czéh, B., & Simon, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110049 · Cited by 30
Parise, E. M., Parise, L. F., Sial, O. K., Cardona-Acosta, A. M., Gyles, T. M., Juarez, B., Chaudhury, D., Han, M., Nestler, E. J., & Bolaños‐Guzmán, C. A. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.002 · Cited by 33
VGF, a New Player in Antidepressant Action?
Malberg, J. E., & Monteggia, L. M. (2008) · Science Signaling · doi:10.1126/stke.118pe19 · Cited by 30
Yamauchi, J., Miyamoto, Y., Kusakawa, S., Torii, T., Mizutani, R., Sanbe, A., Nakajima, H., Kiyokawa, N., & Tanoue, A. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.019 · Cited by 36
Xing, B., Liu, P., Xu, W.-J., Xu, F.-Y., & Dang, Y. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.050 · Cited by 31
Ferreira, C. F., Bernardi, J. R., Bosa, V. L., Schuch, I., Goldani, M. Z., Kapczinski, F. P., Salum, G. A., Dalmaz, C., Manfro, G. G., & Silveira, P. P. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-44 · Cited by 30
“It is a member of the growth factor family and acts as a regulator of synaptic plasticity, synaptogenesis, as well as neuronal survival and differentiation [4-6].”
BackgroundLisowski, P., Juszczak, G. R., Gościk, J., Stankiewicz, A. M., Wieczorek, M., Zwierzchowski, L., & Swiergiel, A. H. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-144 · Cited by 32
“Antidepressant drugs produce antidepressant effects in the prefrontal cortex and hippocampus [31].”
BackgroundZanca, R. M., Braren, S. H., Maloney, B., Schrott, L. M., Luine, V. N., & Serrano, P. A. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00303 · Cited by 36
“These observations suggest that AMPA receptor stabilization is linked to the therapeutic impact of antidepressants involving monoaminergic and glutamatergic signaling (Manji et al., 2001; Berton and Nestler, 2006; Skolnick et al., 2009), a suggestion requiring further investigation.”
BackgroundRecent advances in the neurobiology of depression
(2003) · Advances in Management and Treatment of Depression · doi:10.3109/9780203002889-5 · Cited by 30
Heterotrimeric G Proteins: Insights into the Neurobiology of Mood Disorders
Gonzalez-Maeso, J., & Meana, J. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359586 · Cited by 29
“Alterations in the signal transduction through G proteincoupled receptor (GPCR) pathways [151] [72] have been reported in the etiopathology of mood disorders [117,118, 173].”
BackgroundLi, J., Gong, H., Xu, H., Ding, Q., He, N., Huang, Y., Jin, Y., Zhang, C., Voon, V., Sun, B., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.01024 · Cited by 32
“Some studies also indicate that the brainstem aminergic nuclei is closely associated with late-life depressive symptoms (58, 59).”
BackgroundSupprian, T., Reiche, W., Schmitz, B., Grunwald, I. Q., Backens, M., Hofmann, E. P., Georg, T., Falkai, P., & Reith, W. (2004) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2004.02.005 · Cited by 29
“neuropharmacological and genetic findings, suggest that these disorders have a neurobiological component (Manji et al., 2001; Nestler et al., 2002).”
BackgroundMood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Nugent, A. C., Carlson, P. J., Bain, E., Eckelman, W. C., Herscovitch, P., Manji, H. K., Zarate, C. A., & Drevets, W. C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499204 · Cited by 34
“Alternative mechanisms through which lithium and divalproex may enhance 5-HT1A receptor expression include their neurotrophic/neuroprotective effects, which could increase the neuronal processes expressing 5-HT1A receptor protein (Manji et al., 2001).”
Self-citationDepression and anxiety: Role of mitochondria
Burroughs, S. L., & French, D. (2007) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2007.01.007 · Cited by 40
Sphingolipids in Major Depression
Jernigan, P. L., Hoehn, R. S., Grassmé, H., Edwards, M. J., Müller, C. P., Kornhuber, J., & Gulbins, E. (2015) · Neurosignals · doi:10.1159/000442603 · Cited by 34
Brand, S. J., & Harvey, B. H. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.44 · Cited by 32
“Both depression and PTSD require exposure to stressful events for onset (12), whereas both illnesses exhibit hippocampal atrophy related to hypothalamic–pituitary– adrenal (HPA) axis abnormalities (13).”
BackgroundChromatin Remodeling: A Novel Mechanism of Psychotropic Drug Action
Newton, S. S., & Duman, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027078 · Cited by 33
“, psychostimulants and opiates), demonstrating the plasticity of neural systems at a molecular level (Duman et al., 1997, 2000; Manji et al., 2001; Nestler, 2004).”
BackgroundFunato, H., Kobayashi, A., & Watanabe, Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.029 · Cited by 28
From genetics to systems biology of stress-related mental disorders
Dalvie, S., Chatzinakos, C., Zoubi, O. A., Georgiadis, F., Lancashire, L., & Daskalakis, N. P. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100393 · Cited by 36
Casu, M. A., Sanna, A., Spada, G. P., Falzoi, M., Mongeau, R., & Pani, L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.004 · Cited by 28
Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants
Malkesman, O., Austin, D. R., Tragon, T., Henter, I. D., Reed, J. C., Pellecchia, M., Chen, G., & Manji, H. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.77 · Cited by 29
Self-citationKim, J.-M., Kim, S.-W., Stewart, R., Kim, S.-Y., Shin, I., Park, M., Yoon, J.-H., Lee, J., Park, S.-W., Kim, Y.-H., et al. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318241530c · Cited by 28
“Because BDNF is the most abundant neurotrophin in the brain and has antidepressant neuroprotective effects (30), functional deficiency might increase depressogenic effects of biologic insults and/or psychological stresses.”
BackgroundNeuroplasticity — A New Approach to the Pathophysiology of Depression
Fuchs, E. (2011) · doi:10.1007/978-1-908517-18-0_1 · Cited by 28
Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction
Tizabi, Y., Getachew, B., Hauser, S. R., Tsytsarev, V., Manhães, A. C., & da Silva, V. D. A. (2024) · Brain Sciences · doi:10.3390/brainsci14060558 · Cited by 27
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Puga-Olguín, A., Flores-Soto, M. E., Nápoles-Medina, A. Y., Muñoz‐Carrillo, J. L., Rodríguez‐Landa, J. F., & Soria-Fregozo, C. (2025) · Biomedicines · doi:10.3390/biomedicines13081831 · Cited by 33
“Therefore, depression may be associated with an impairment of structural plasticity and cellular resilience, and antidepressant pharmacological therapies may act to normalize this impairment [90].”
Pan, L. A., Keener, M. T., Hassel, S., & Phillips, M. L. (2009) · International Review of Psychiatry · doi:10.1080/09540260902962164 · Cited by 33
Na+,K+-ATPase activity in an animal model of mania
Zugno, A. I., Valvassori, S. S., Scherer, E. B. S., de Mattos, C. B., Matté, C., Ferreira, C. L., Rezin, G. T., Wyse, Â. T. D. S., Quevedo, J., & STRECK, E. L. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0198-9 · Cited by 28
Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex
Djordjevic, A. D., Djordjevic, J., Elaković, I., Adžić, M., Matić, G. M., & Radojcic, M. B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.042 · Cited by 29
“Both antidepressants and stress can affect a number of factors involved in cell survival pathways controlling Bcl-2 expression (Manji et al., 2001), among which is the nuclear factor kappa B (NFkB) (Kucharczak et al., 2003).”
BackgroundFerreira, C. F., Bernardi, J. R., Krolow, R., Arcego, D. M., Fries, G. R., de Aguiar, B. W., Senter, G., Kapczinski, F. P., Silveira, P. P., & Dalmaz, C. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.03.006 · Cited by 33
“Brain-derived neurotrophic factor (BDNF) is a dimeric protein that plays a key role in synaptic plasticity and neuronal survival (Manji et al., 2001; Poo, 2001).”
Neuroimaging and Neuropathological Studies of Mood Disorders
Drevets, W. C., & Price, J. L. (2005) · Biology of Depression · doi:10.1002/9783527619672.ch17 · Cited by 26
Self-citationAlghamdi, A., Almuqbil, M. S., Alrofaidi, M. A., Burzangi, A. S., Alshamrani, A. A., Alzahrani, A. R., Kamal, M., Imran, M., Alshehri, S., Mannasaheb, B. A., et al. (2022) · Molecules · doi:10.3390/molecules27249055 · Cited by 26
“The primary reasons include alterations in monoamine neurotransmitters [2], as well as increased oxidative and nitrosative damage [3].”
BackgroundCarlson, J. M., DePetro, E., Maxwell, J. W., Harmon‐Jones, E., & Hajcak, G. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.005 · Cited by 27
“Traditionally, reduced mPFC volumes, as well as reductions in the volumes of other brain regions, in depression were hypothesized to be caused by stress-initiated hypercortisolemic glucocorticoid-mediated cell death (Manji et al., 2001; Frodl et al., 2008).”
BackgroundWu, S., HSU, L., TU, W., Wang, W., HUANG, Y., Pawlak, C. R., & HO, Y. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.013 · Cited by 26
Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression
Landau, A. M., Phan, J.-A., Iversen, P., Lillethorup, T. P., Simonsen, M., Wegener, G., Jakobsen, S., & Doudet, D. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.025 · Cited by 28
“However, several decades of intense pharmacological research have demonstrated the contribution of monoaminergic transmission to the disease (Manji et al., 2001; Schildkraut, 1965).”
BackgroundAlzheimer's Disease and Depression: Preclinical Comorbidity Effects on Cognitive Functioning
BERGER, A., Fratiglioni, L., Winblad, B. G., & Bäckman, L. (2005) · Cortex · doi:10.1016/s0010-9452(08)70200-4 · Cited by 29
Causality of stem cell based neurogenesis and depression – To be or not to be, is that the question?
Feldmann, R. E., Sawa, A., & Seidler, G. H. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.06.007 · Cited by 30
“It is also being discussed if major depression is not a primary hippocampal disorder (Manji et al., 2001; Nestler et al., 2002) and if not (impaired) NG represents only the most prominent aspect of a more general theory of cellular plasticity (Kempermann and Kronenberg, 2003).”
BackgroundEffect of acupuncture stimulation on rats with depression induced by water-immersion stress
Tanahashi, N., Takagi, K., Amagasu, N., Wang, G., Mizuno, K., Kawanoguchi, J., Guo, Y., & Ishida, T. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.051 · Cited by 26
Imaging the Neural Systems for Motivated Behavior and Their Dysfunction in Neuropsychiatric Illness
Breiter, H. C., Gasic, G. P., & Makris, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-33532-2_33 · Cited by 31
Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression
Hochschild, A., Keilp, J. G., Madden, S. P., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.055 · Cited by 25
Treadmill exercise alleviates chronic mild stress-induced depression in rats
Lee, T.-H., Kim, K.-J., Shin, M., Kim, C., & Lim, B. (2015) · Journal of Exercise Rehabilitation · doi:10.12965/jer.150265 · Cited by 29
“In the prefrontal and cingulated cortex, metabolism and volume are reduced in depression patients (Manji et al., 2001; Manji and Duman, 2001).”
BackgroundHoney on brain health: A promising brain booster
Zamri, N. A., Ghani, N., Ismail, C. A. N., Zakaria, R., & Shafin, N. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1092596 · Cited by 34
“In experimental animals, this causes to hippocampal shrinkage and neuronal loss (McEwen, 1999), which is supported by lower hippocampus volume in depressed people (Manji et al., 2001).”
BackgroundFreitas, T. P., Rezin, G. T., Gonçalves, C. L., Jeremias, G. C., Gomes, L. M., Scaini, G., Teodorak, B. P., Valvassori, S. S., Quevedo, J., & STRECK, E. L. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0455-0 · Cited by 25
Miyata, S., Hamamura, T., Lee, Y., Miki, M., Habara, T., Oka, T., Endo, S., Taoka, H., & Kuroda, S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2072-7 · Cited by 25
“In depressive patients, recent neuroimaging studies have been consistent in demonstrating dysfunction of the prefrontal cortex (Manji et al. 2001).”
BackgroundWhite matter atrophy and myelinated fiber disruption in a rat model of depression
Gao, Y., Ma, J., Tang, J., Liang, X., Huang, C., Wang, S., Chen, L., Wang, F., Tan, C., Chao, F., et al. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24178 · Cited by 25
Overexpression of SIRT1 Inhibits Corticosterone-Induced Autophagy
Jiang, Y., Botchway, B. O. A., Hu, Z., & Fang, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.035 · Cited by 26
Guelman, L. R., Zubilete, M. A. Z., Ríos, H., & Zieher, L. M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00136-5 · Cited by 27
Pereira-Figueiredo, I., Sancho, C., Carro, J., Castellano, O., & pez, D. E. L. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00260 · Cited by 26
Claw, K. G., Tito, R. Y., Stone, A. C., & Verrelli, B. C. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msq030 · Cited by 26
“2006), which downregulates brain-derived neurotrophic factor that is linked to increased depression (Vaidya et al. 1997; Manji et al. 2001).”
BackgroundPerisynaptic astrocytes as a potential target for novel antidepressant drugs
Frizzo, M. E., & Ohno, Y. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.11.002 · Cited by 26
Mahesh, R., Jindal, A., Gautam, B., Bhatt, S., & Pandey, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.075 · Cited by 25
“According to World Health Organization, it will be the second largest global burden of disease by the year 2020, illustrating the severity and impact of the disorder [3,4].”
BackgroundIshii, T., Hashimoto, E., Ukai, W., Tateno, M., Yoshinaga, T., Saitô, S., Sohma, H., & Saito, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.021 · Cited by 27
“However, recent studies have demonstrated neuroprotective and neurotrophic actions of lithium which could be related to its clinical effectiveness (Chen et al., 2000; Manji et al., 2001).”
BackgroundGautam, B., Jindal, A., Dhar, A. K., & Mahesh, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.006 · Cited by 27
“According to World Health Organization by the year 2020, it will be the second largest global burden of disease, illustrating the severity and impact of the disorder (Manji et al., 2001; Nestler et al., 2002).”
Xu, F., Yang, H. J., Chen, J., Wu, Q., Gong, W., Zhang, J., Shao, W., Mu, J., Yang, D., Yang, Y., et al. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0543-y · Cited by 25
“One reason is our insufficient understanding of the neurobiological basis of MDD [26,30].”
Gui, Z. H., Zhang, Q. J., Liu, J.-R., Ali, U., Li, L., Wang, Y., Wang, T., Chen, L., Hou, C., & Fan, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.059 · Cited by 23
Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis
Kaur, M., Lagopoulos, J., Ward, P. B., Watson, T., Naismith, S. L., Hickie, I. B., & Hermens, D. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051871 · Cited by 23
“Excessive activity of NMDA receptors has been implicated in mood disorders [81,82] and treatment with mood stabilisers (i.”
BackgroundProspective Memory Deficits in Patients with Bipolar Disorder: A Preliminary Study
Lee, E. H. M., Xiang, Y., Man, D. W. K., Au, R. W. C., Shum, D., Tang, W. K., Chiu, H. F. K., Wong, P., & Ungvari, G. S. (2010) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acq061 · Cited by 25
The healing power of well-being
Mathew, J., & Paulose, C. S. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00578.x · Cited by 28
“Moreover, depression has been associated with alterations in peptidergic function, including corticotropin-releasing hormone (CRH), arginine vasopressin, neuromedin B and substance P, and growth factors (16).”
BackgroundMoretti, M., Budni, J., Ribeiro, C. M., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.004 · Cited by 24
“Despite the molecular and cellular adaptations that underlie therapeutic action of antidepressants are not entirely understood, changes in neuronal plasticity and cellular resilience have been implicated in both etiology of major depressive disorder (MDD) and antidepressant drug action [11–13].”
BackgroundMizutani, R., Yamauchi, J., Kusakawa, S., Nakamura, K., Sanbe, A., Torii, T., Miyamoto, Y., & Tanoue, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.06.005 · Cited by 21
Laifenfeld, D., Karry, R., Grauer, E., Klein, E., & Ben‐Shachar, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300357 · Cited by 25
“For example, in the frontal cortex, there are reports of abnormalities in brain volume and metabolism in post-mortem brains of depressed patients (Drevets et al, 1997; Rajkowska et al, 1999; Rajkowska 2000; Manji et al, 2001).”
BackgroundKurhe, Y., & Mahesh, R. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.07.007 · Cited by 24
“According to the World Health Organization depression would be a second largest global burden in terms of disease severity and disability (Manjit et al., 2001; Nestler et al., 2002).”
BackgroundProteomic approaches to central nervous system disorders
Rohlff, C., & Southan, C. (2015) · PubMed · doi:10.6084/m9.figshare.1415926 · Cited by 23
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Taylor, A. P., Mortari, M. R., & Caldas, E. D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00854-w · Cited by 23
Zaheed, A. B., Chervin, R. D., Spira, A. P., & Zahodne, L. B. (2022) · SLEEP · doi:10.1093/sleep/zsac262 · Cited by 26
Li, X., Hu, J., Zang, X., Xing, J., Mo, X., Hei, Z., Gong, C., Chen, C., & Zhou, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03499-1 · Cited by 23
“The signaling pathways related to neuronal cell survival and death are considered long-term targets for antidepressants[33].”
BackgroundBecker, I. (2008) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570450410 · Cited by 23
Botanas, C. J., de la Peña, J. B., Custodio, R. J. P., Peña, I. J. D., Kim, M., Woo, T., Kim, H. J., Kim, H. I., Cho, M. C., Lee, Y. S., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.038 · Cited by 24
“Conventional antidepressants target the serotonergic system by inhibiting serotonin reuptake and/or modulating serotonin receptors (Manji et al., 2001).”
A proteomic investigation of similarities between conventional and herbal antidepressant treatments
Pennington, K., Föcking, M., McManus, C., Pariante, C. M., Dunn, M., & Cotter, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091075 · Cited by 25
Lee, Y., Lin, P., Chiu, N., Chang, W., & Wen, J.-K. (2002) · PubMed · Cited by 22
Lieb, K., Treffurth, Y., Hamke, M., Akundi, R. S., Kleinsorgen, M. V., & Fiebich, B. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01802.x · Cited by 22
Horowitz, J. M., Goyal, A., Ramdeen, N., Hallas, B. H., Horowitz, A., & Torres, G. (2003) · Synapse · doi:10.1002/syn.10276 · Cited by 22
“…prefrontal cortex and hippocampus, along with their local circuits, respond to antidepressant and antipsychotic drug therapy by upregulating the cAMP pathway, including the expression of the cAMP response element binding protein (CREB; Nibuya et al., 1996; Duman et al., 1999; Manji et al., 2001).”
Jagielska, A., Sałaciak, K., & Pytka, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102635 · Cited by 26
Shi, X., Zhang, Q., Li, J., Liu, X., Zhang, Y., Huang, M., Fang, W., Xu, J., Yuan, T., Xiao, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109612 · Cited by 25
Croce, N., Mathé, A. A., Gelfo, F., Caltagirone, C., Bernardini, S., & Angelucci, F. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114529379 · Cited by 27
“Preclinical studies suggest that the expression of BDNF might be a downstream target of antidepressant treatments and mood stabilizers and that BDNF exerts antidepressant activity in animal models of depression (Manji et al., 2001).”
BackgroundImplication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses
Razzoli, M., Bo, E., Pascucci, T., Pavone, F., D'Amato, F. R., Cero, C., Sanghez, V., Dadomo, H., Palanza, P., Parmigiani, S., et al. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.038 · Cited by 25
Jayaweera, H. K., Lagopoulos, J., Duffy, S. L., Lewis, S. J. G., Hermens, D. F., Norrie, L. M., Hickie, I. B., & Naismith, S. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.023 · Cited by 23
Varman, D. R., Marimuthu, G., & Rajan, K. E. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23165 · Cited by 22
“These behavioral changes are thought to arise from complex interactions between multiple genetic and environmental factors (Manji et al., 2001).”
BackgroundOng, M., Tuan, T. A., Poh, J., Teh, A. L., Chen, L., Pan, H., MacIsaac, J. L., Kobor, M. S., Chong, Y. S., Kwek, K., et al. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12576 · Cited by 20
Ma, L., Hu, P. L., Zhang, J., Cui, W., & Zhao, X. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05422-w · Cited by 21
Okan, S., Türk, A. Ç., Şıvgın, H., Özsoy, F., & Okan, F. (2019) · Croatian Medical Journal · doi:10.3325/cmj.2019.60.515 · Cited by 24
Specific hippocampal choline decrease in an animal model of depression
Hong, S.-T., Choi, C.-B., Park, C., MOON, H.-Y., Hong, K. S., Cheong, C., Chae, J.-H., & Choe, B. (2009) · British Journal of Radiology · doi:10.1259/bjr/25165760 · Cited by 22
McNab, J. A., Voets, N., Jenkinson, N., Squier, W., Miller, K. L., Goodwin, G. M., & Aziz, T. Z. (2009) · Journal of neurosurgery · doi:10.3171/2009.2.jns081299 · Cited by 21
What makes a drug a primary mood stabilizer?
Keck, P. E., McElroy, S. L., Richtand, N. M., & Tohen, M. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001013 · Cited by 23
Modern proteomic strategies in the study of complex neuropsychiatric disorders
Rohlff, C., & Hollis, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00233-6 · Cited by 21
Christou, A. I., Endo, S., Wallis, Y., Bair, H., Zeegers, M. P., & McCleery, J. P. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000413 · Cited by 21
Hu, H., Xue, Y., He, Y., Duan, C., & Sun, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02569-w · Cited by 23
“However, the excessive synthesis and release of glucocorticoids in response to repeated stressful experiences disrupts the negative feedback mechanisms of HPA axis, causing functional damage to the hippocampus [6].”
BackgroundClinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validity
Ghaemi, S. N., Angst, J., Vöhringer, P. A., Youngstrom, E. A., Phelps, J. R., Mitchell, P. B., McIntyre, R. S., Bauer, M., Vieta, E., & Gershon, S. (2022) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00267-3 · Cited by 20
Translating depression biomarkers for improved targeted therapies
Bredt, D. S., Furey, M. L., Chen, G., Lovenberg, T., Drevets, W. C., & Manji, H. K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.013 · Cited by 23
Self-citationJeon, H. J., Woo, J., Lee, S.-H., Kim, E.-J., Chung, S., Ha, J. H., Fava, M., Mischoulon, D., Kim, J., Heo, J.-Y., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000072 · Cited by 26
Melatonin Acts as an Antidepressant by Inhibition of the Acid Sphingomyelinase/Ceramide System
Hoehn, R. S., Monse, M., Pohl, E., Wranik, S., Wilker, B., Keitsch, S., Soddemann, M., Kornhuber, J., Kohnen, M., Edwards, M. J., et al. (2016) · Neurosignals · doi:10.1159/000442611 · Cited by 21
Integrating Endocannabinoid Signalling In Depression
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Kumar, R., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01774-7 · Cited by 20
Effects of Antidepressant Drug Imipramine on Gene Expression in Rat Prefrontal Cortex
Knuuttila, J. E. A., Törönen, P., & Ċastrén, E. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023610.89631.d6 · Cited by 23
“In this context, much interest has been directed to changes in intracellular signal transduction that takes place in response to acute or chronic antidepressant drug treatment (4,5).”
Background
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.